📈 DAWN, MRVL surge as median stock slips—most active stocks today & high volume market movers | March 7, 2026
Eyes on DAWN, MRVL, IOVA. Intraday activity is driven by concentrated volume spikes in biotech and semiconductor names, with DAWN and MRVL showing the most pronounced breakouts by volume and price. Breadth is weak—median price change is negative and median volume uplift is modest—so confirm moves with sustained volume before treating them as durable. Risk is elevated due to speculative/unprofitable names and several high-valuation stocks; the data suggests prioritizing volume-confirmed momentum and using disciplined exits.
Top Picks
Disclaimer: This AI-generated analysis is for educational and informational purposes only. It does not constitute financial advice. Always do your own research and consult with a licensed financial advisor before making investment decisions.
Market Overview
Key Observation
Intraday activity is dominated by a few outsized volume/momentum winners (notably DAWN and MRVL) while the median stock shows negative price change and only a modest volume uptick versus its 3-month average.
Volume Analysis
Median volume spike is only 1.1x, indicating limited breadth; volume is highly concentrated in a handful of names (DAWN 28.61x, MRVL 5.97x, IOVA 3.18x). Several liquid large-cap names show muted volume ratios (~1x or lower), suggesting most intraday liquidity and volatility is concentrated in speculative/sector-specific movers (biotech and semiconductors).
Top PicksShowing 2 of 5
DAWN
Analysis
The data shows an extreme intraday volume surge (volume_ratio 28.61) combined with a very large price move (+65.88%) and a range_position at 99.8% of the 52-week range—classic signs of an accelerated breakout or news-driven re-rate. Market cap remains modest ($2.19B) and valuation is marked 'Unprofitable', consistent with speculative biotech behavior. Momentum_score is high (80) which aligns with the price/volume breakout.
Key Metrics
change_pct +65.88%, volume_ratio 28.61, range_position 99.8
Risk Factors
Unprofitable valuation; extreme, short-lived spikes common in small-cap biotech names.
Suggested Action
The data suggests monitoring intraday tape and follow-through volume; watch for sustained >2–3x average volume and closing above the intraday break level before treating the move as durable.
MRVL
Analysis
Marvell shows a strong momentum profile: sizable intraday price gain (+18.35%) with a large volume spike (volume_ratio 5.97), momentum_score 80 and uptrend status. It sits well into its 52-week range (76.3%), indicating participation in the broader semiconductor advance rather than a low-liquidity pop.
Key Metrics
change_pct +18.35%, volume_ratio 5.97, momentum_score 80
Risk Factors
Valuation metrics (PE 31.5, PB 5.3) indicate stretched multiples relative to cyclicality.
Suggested Action
The data suggests watching for continuation with above-average volume and intraday price confirmation (higher lows on increased volume); use clear exit rules if volume wanes.
+3 more top picks available
Sign up free to unlock all picks
Unlock Full Analysis
Sign up for free to access the complete Most Active Stocks analysis
You're missing out on:
By signing up, you agree to our Terms of Service and Privacy Policy